AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：

AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：

中国大学MOOC: AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：

According to biologist Sandra Steingraber, it’s important for people to recognize _______. A: the public health implications of medicalization B: the side-effects of non-prescription drugs C: the high concentration of drugs in drinking wate D: the importance of filtering out pharmaceuticals

曼斯菲尔德制药公司（Mansfield Pharmaceuticals）销售抗生素Zipro。该公司的固定成本为1,000,000元，可变成本为每瓶50片2元，定价为每瓶10元。盈亏平衡量是多少瓶？? 55,000|100,000|115,000|125,000